Institutional investors purchased a net $1.1 million shares of ICLR during the quarter ended September 2016 and now own 97.29% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 10.3 Thousand shares of ICON PLC
EQIS CAPITAL MANAGEMENT, INC. Bought 3.1 Thousand shares of ICON PLC
RELIANCE TRUST COMPANY OF DELAWA... Bought 2.0 Thousand shares of ICON PLC